期刊文献+

HPLC法测定甲氨蝶呤片含量的方法学研究 被引量:1

Content Determination of Active Ingredients in Methotrexate Tablets by HPLC
下载PDF
导出
摘要 建立一种液相色谱分析方法,测定甲氨蝶呤片的含量。采用色谱柱Inertsil ODS-2 (25 cm×4.6 mm,5μm);以乙腈-磷酸盐缓冲液(5︰95)为流动相;检测波长为302 nm;流速为1.0 mL/min;采集时间为20 min;进样体积为20μL。结果显示甲氨蝶呤线性范围为36.07~108.22μg·mL^(-1)(r=1.000);甲氨蝶呤平均回收率为99.1%,RSD为0.4%。该方法简单准确、重复性好,可用于甲氨蝶呤片的含量测定。 The high-performance liquid chromatography(HPLC) method was established to determine the content of methotrexate tablets. Methotrexate was determined by HPLC as follows: chromatographic column, Inertsil ODS-2(25 cm×4.6 mm, 5 μm);mobile phase, acetonitrile-phosphate buffer(5:95);detection wavelength, 302 nm;flow rate, 1.0 mL/min;acquisition time, 20 min;injection volume, 20 μL. The liner range of methotrexate was 36.07~108.22 μg·mL^(-1)(r=1.000). The average recovery rate of methotrexate(n=9) was 99.1 % with its RSD value of 0.4 %. The method was simple, accurate and repeatable, which was suitable for the content determination of active ingredients in methotrexate tablets.
作者 刘永波 Liu Yongbo(R&D center,Sinomune Pharmaceutical Co.,Ltd.,Wuxi 214194,China)
出处 《广东化工》 CAS 2022年第5期170-172,共3页 Guangdong Chemical Industry
关键词 HPLC 甲氨蝶呤 方法学 含量 准确度 HPLC methotrexate methodology assay accuracy
  • 相关文献

参考文献4

二级参考文献60

  • 1张林,黄继军.中国蒙古族银屑病流行调查报告[J].中华皮肤科杂志,1989,22(4):219-221. 被引量:5
  • 2[1]Weinstein GD, Frost P. Methotrexate for psoriasis, A new therapeutic schedule. Arch Dermatol, 1971, 103 ( 1 ): 33 -38.
  • 3[2]Said S, Jeffes EW, Weinstein GD. Methotrexate. Clin Dermatol, 1997, 15(5) :781 - 797.
  • 4[3]Primka EJ 3rd, Camisa C. Methotrexate - induced toxic epidermal necrolysis in a patient with psoriasis. J Am Acad Dermatol, 1997, 36(5 Pt 2): 815 - 818.
  • 5[5]Sprecher E, Bergman R, Sprecher H, et al. Reduced folate carrier (RFC - 1) gene expression in normal and psoriatic skin. Arch Dermatol Res, 1998, 290(12) :656- 660.
  • 6[6]Jeffes EW 3rd, McCullough JL, Pittelkow MR, et al. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth - inhibitory effects of methotrexate. J Invest Dermatol, 1995, 104(2): 183-188.
  • 7[7]Jeffes EW 3rd, Lee GC, Said S, et al. Elevated numbers of proliferating mononuclear cells in the peripheral blood of pso riatic patients correlate with disease severity. J Invest Dermatol, 1995, 105(6): 733- 738.
  • 8[8]Yamasaki E, Soma Y, Kawa Y, et al. Methotrexate inhibits proliferation and regulation of the expression of intercellular adhesion molecule - 1 and vascular cell adhesion molecule - 1 by cultured human umbilical vein endothelial cells. Br J Der matol, 2003, 149( 1 ): 30 - 38.
  • 9[9]Piskin G, Heydendael VM, de Rie MA, et al. Cyclosporin A and methotrexate are equally effective in reducing T cell numbers in psoriatic skin lesions but have no consistent effect on IFN - gamma and IL - 4 expression in psoriatic skin in situ. Arch Dermatol Res, 2003, 294(12) :559 - 562.
  • 10[11]Jeffes EW 3rd, McCullough JL, Pittelkow MR, et al. Methotrexate therapy of psoriasis: differential sensitivity of proliferating lymphoid and epithelial cells to the cytotoxic and growth- inhibitory effects of methotrexate, J Invest Dermatol, 1995, 104(2): 183-188.

共引文献195

同被引文献21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部